Olive C - Search Results

1

Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides.

Olive C, Hsien K, Horváth A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Vaccine. 2005 Mar 18;23(17-18):2298-303. doi: 10.1016/j.vaccine.2005.01.041. Vaccine. 2005. PMID: 15755615

2

Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation.

Olive C, Schulze K, Sun HK, Ebensen T, Horváth A, Toth I, Guzman CA. Olive C, et al. Vaccine. 2007 Feb 26;25(10):1789-97. doi: 10.1016/j.vaccine.2006.11.031. Epub 2006 Nov 30. Vaccine. 2007. PMID: 17229503

3

Towards the development of a broadly protective group a streptococcal vaccine based on the Lipid-Core Peptide system.

Olive C, Moyle PM, Toth I. Olive C, et al. Curr Med Chem. 2007;14(28):2976-88. doi: 10.2174/092986707782794069. Curr Med Chem. 2007. PMID: 18220734 Review.

4

Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes.

Horvath A, Olive C, Wong A, Clair T, Yarwood P, Good M, Toth I. Horvath A, et al. Among authors: olive c. J Med Chem. 2002 Mar 14;45(6):1387-90. doi: 10.1021/jm0110441. J Med Chem. 2002. PMID: 11882009

5

A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies.

Olive C, Batzloff MR, Horváth A, Wong A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Infect Immun. 2002 May;70(5):2734-8. doi: 10.1128/IAI.70.5.2734-2738.2002. Infect Immun. 2002. PMID: 11953422 Free PMC article.

6

Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope.

Olive C, Clair T, Yarwood P, Good MF. Olive C, et al. Vaccine. 2002 Jun 21;20(21-22):2816-25. doi: 10.1016/s0264-410x(02)00205-0. Vaccine. 2002. PMID: 12034109

7

Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.

Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Infect Immun. 2003 May;71(5):2373-83. doi: 10.1128/IAI.71.5.2373-2383.2003. Infect Immun. 2003. PMID: 12704107 Free PMC article.

8

Lipid core peptide technology and group A streptococcal vaccine delivery.

Olive C, Batzloff MR, Toth I. Olive C, et al. Expert Rev Vaccines. 2004 Feb;3(1):43-58. doi: 10.1586/14760584.3.1.43. Expert Rev Vaccines. 2004. PMID: 14761243 Free article. Review.

9

Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct.

Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Indian J Med Res. 2004 May;119 Suppl:88-94. Indian J Med Res. 2004. PMID: 15232170

10

Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage.

Horváth A, Olive C, Karpati L, Sun HK, Good M, Toth I. Horváth A, et al. Among authors: olive c. J Med Chem. 2004 Jul 29;47(16):4100-4. doi: 10.1021/jm040041w. J Med Chem. 2004. PMID: 15267249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters